I have just read a report from Mike Scott of a 64-year-old Croatian man who was recently diagnosed with advanced prostate cancer. His PSA was 21,380 ng/ml! Yes, I said a PSA of 21,380. Now, hold on to your seats for even more intriguing information. According to the report this man has never experienced any [...]
Some interesting information was presented at the Society of Interventional Radiology’s 35th Annual Scientific Meeting just held in Tampa, Fl. A potential future use of magnetic resonance (MR)-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat the recurrence of prostate cancer after the surgical removal of the prostate gland (and in some cases [...]
I have been reading in the press about a recent medical malpractice settlement surrounding prostate cancer. Briefly, a man went to his primary care physician who, along with other tests, performed a DRE and PSA test. The doctor failed to inform his patient about the negative test results which were indicative of a diagnosis of [...]
Roche Pharmaceuticals has reported that their clinical trial of Avastin in men with advanced prostate cancer did not improve their overall life expectancy. […]
Watson Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Trelstar – 22.5 mg (triptorelin pamoate for injectable suspension) at a dosage which will be required only to be administered twice a year. […]